JP Morgan Maintains Neutral on Inspire Medical Systems, Raises Price Target to $65
Benzinga Newsdesk 20 hours ago
Analyst RatingsNewsPrice Target
JP Morgan analyst Robbie Marcus maintains Inspire Medical Systems (NYSE:INSP) with a Neutral and raises the price target from $60 to $65.
JP Morgan analyst Robbie Marcus maintains Inspire Medical Systems (NYSE:INSP) with a Neutral and raises the price target from $60 to $65.